ANI Pharmaceuticals, Inc. Announces FDA Approval And Launch Of Pimozide Tablets

Published: 2026-04-20 12:38:40 ET ANIP

Published on 04/20/2026 at 12:38 pm EDT

ANI Pharmaceuticals, Inc. announced the launch of Pimozide Tablets 1 mg and 2 mg. ANI?s Pimozide Tablets is the generic version of the reference listed drug (RLD) Orap®. U.S. annual sales for Pimozide Tablets total approximately $3.1 million, based on February 2026 moving annual total (MAT) IQVIA data.